Spironolactone Tablet
Product Images NDC 72603-135

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 72603-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Spironolactone Fig1)

A survival probability graph comparing spironolactone and placebo groups over 42 months. The x-axis represents months, and the y-axis shows probability. The chart includes sample sizes: 822 for spironolactone and 841 for placebo, with a reported log-rank p-value of less than 0.001.*

FDA Label Image

Fig2 (Spironolactone Fig2)

A forest plot chart depicting hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups related to Spironolactone treatment. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, and use of digoxin, ACE inhibitors (ACEI), and beta blockers. The horizontal axis compares Spironolactone better versus placebo better.*

FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

Label for Spironolactone Tablets USP 25 mg, containing 100 tablets. The label shows the NDC number 72603-134-01 and states the product is manufactured by Aurobindo Pharma Limited and distributed by Northstar Rx LLC. Storage, handling, and dosage information are briefly noted.*

FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))

Label for Spironolactone Tablets USP 50 mg by NorthStar Rx LLC, containing 100 tablets. The label includes storage instructions to keep at 20° to 25°C and protect from light. Manufactured by Aurobindo Pharma Limited, Hyderabad, India, and distributed by NorthStar Rx LLC, Memphis, TN. The label also displays the NDC code 72603-135-01 and issuance date 03/2023.*

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Tablets Bottle))

Label for Spironolactone Tablets, USP 100 mg oral tablets by NorthStar Rx LLC. The label states it contains 100 tablets per container. It includes storage instructions, manufacturing details, and a barcode. Manufactured by Aurobindo Pharma Limited, Hyderabad, India.*

FDA Label Image

Str1 (Spironolactone Str1)

Chemical structure of spironolactone displayed as a molecular diagram showing rings, bonds, and functional groups including ketone and thioester groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.